SCHEMBL6586598

SCHEMBL6586598

Nc1cccc2ccc(O)c(F)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 1/20 0.40
CYP17A1 P05093 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
JAK2 O60674 1/20 0.39
RPS6KA3 P51812 1/20 0.39
MELK Q14680 1/20 0.39
STK24 Q9Y6E0 1/20 0.39
GLO1 Q04760 1/20 0.39
TSHR P16473 4/20 0.39
CYP3A4 P08684 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP1B1 Q16678 1/20 0.39
ALOX15 P16050 1/20 0.38
PLAU P00749 3/20 0.37
NCF1 P14598 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11921498 0.79 CDK2 (0.42) CDK2JAK2RPS6KA3MELKSTK24
SCHEMBL5374043 0.79 CDK2 (0.42) CDK2JAK2RPS6KA3MELKSTK24
SCHEMBL6488214 0.79 MAPT (0.46) CDK2CYP17A1CYP11B1CYP11B2TSHR
SCHEMBL444774 0.76 TSHR (0.52) CDK2JAK2RPS6KA3MELKSTK24
SCHEMBL30845313 0.76 TSHR (0.52) CDK2JAK2RPS6KA3MELKSTK24
SCHEMBL29365168 0.76 TSHR (0.52) CDK2JAK2RPS6KA3MELKSTK24
SCHEMBL14742902 0.75 ALDH1A1 (0.59) JAK2RPS6KA3MELKSTK24TSHR
Catechol SCHEMBL8517030 0.74 ALOX15 (0.56) CDK2JAK2RPS6KA3MELKSTK24
SCHEMBL7916033 0.74 TSHR (0.50) CDK2JAK2RPS6KA3MELKSTK24
Hydrochloric Acid SCHEMBL31157040 0.74 TSHR (0.50) CDK2JAK2RPS6KA3MELKSTK24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259875-A1 Amine derivatives BAYER HEALTHCARE AG (DE) 2004-12-23 US disclosed
EP-1414788-A1 NAPHTHYLUREA AND NAPHTHYLACETAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) ANTAGONISTS Bayer HealthCare AG (DE) 2004-05-06 EP disclosed
WO-2003014064-A1 NAPHTHYLUREA AND NAPHTHYLACETAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) ANTAGONISTS BAYER HEALTHCARE AG (DE) 2003-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259875-A1 Amine derivatives AVPR1A, GRIN1, OPRL1 CDK2 2475/4885CYP17A1 3939/4885CYP11B1 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.